FindMyKOL
Clinical trialNCT02155595CompletedObservational

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy

NCT02155595 is an observational study sponsored by Henry Ford Health System. As of 21 Nov 2026, it is completed. It studies Atypical Femoral Fractures, Osteoporosis and 1 more condition. The registry lists an enrollment of 738 participants at 1 site in 1 country. The registry lists a start date of 31 May 2014 and a primary completion date of 31 Aug 2018.

SponsorHenry Ford Health System →Enrollment738Atypical Femoral FracturesOsteoporosisProdromal Bone Deterioration
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02155595
FieldValue
Registry IDNCT02155595
StatusCompleted
Study typeObservational study
Lead sponsorHenry Ford Health System
Enrollment738
Registered sites1
Countries1
ConditionsAtypical Femoral Fractures, Osteoporosis and Prodromal Bone Deterioration
Start31 May 2014
Primary completion31 Aug 2018
Study completion31 Aug 2018
Last update posted29 Mar 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this protocol is to determine the risk of atypical femoral shaft (thigh bone) fractures after long term fracture prevention therapy with a class of drugs called "bisphosphonates", colloquially referred to as Alendronate, risedronate, Ibandronate, and Zoledronate. In addition, the study is designed to find out which patient is most likely to develop this potential life changing complication and why. Finally, the results of this study will help clinicians to better understand the reason and thus tailor patient specific treatments…i.e., "the right treatment for the right patient for right duration."

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Michigan, United States1 site
  • Henry Ford Medical Center, New Center One

    Detroit

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichigan: 1 siteMI1New YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02155595

Each answer restates registry values shown on this page.

What is NCT02155595?

NCT02155595 is an observational study sponsored by Henry Ford Health System. It studies Atypical Femoral Fractures, Osteoporosis and 1 more condition.

Who leads NCT02155595?

The registry names Sudhaker D. Rao, M.B;B.S. (principal investigator, Henry Ford Health System) as the overall official.

Where does NCT02155595 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02155595 end?

The registry lists a primary completion date of 31 Aug 2018 and a study completion date of 31 Aug 2018. The sponsor last updated the record on 29 Mar 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.